Home › Varian ProBeam Proton Therapy System First to Receive Saudi FDA Authorization
 

Keywords :   


Varian ProBeam Proton Therapy System First to Receive Saudi FDA Authorization

2016-01-15 11:31:11| Industrial Newsroom - All News for Today

RIYADH, Saudi Arabia - Varian Medical Systems (NYSE: VAR) has announced today its ProBeam proton therapy system is the first such system to receive Saudi FDA medical devices marketing authorization. "We are pleased to have the opportunity to make life-saving proton therapy treatments available to cancer patients...

Tags: system receive therapy saudi

Category:Industrial Goods and Services

Latest from this category

All news
17.05Next MANAchat Series Scheduled for the Week of June 10
15.05Relationship Reviews Strengthening the Partnership Between Manufacturer and Rep
14.05Consolidated Financial Statements for the twelve-month period ended March 31, 2024
14.05Actions to Implement Management that is Conscious of Cost of Capital and Stock Price
Industrial Goods and Services »
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Producers to be paid grid premiums for AngusLink beef scores
18.05This Week in Agribusiness, May 18, 2024
18.05This Week in Agribusiness, May 18, 2024
18.05Unpaid carers being forced to repay 250m to DWP
18.05Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories
18.05Eastern North Pacific Tropical Weather Outlook
More »